Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Diplomat Pharmacy Inc (DPLO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 410,440
  • Shares Outstanding, K 74,490
  • Annual Sales, $ 5,493 M
  • Annual Income, $ -302,270 K
  • 60-Month Beta 0.72
  • Price/Sales 0.07
  • Price/Cash Flow 1.18
  • Price/Book 0.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.07
  • Number of Estimates 7
  • High Estimate 0.10
  • Low Estimate 0.03
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -65.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.99 +8.82%
on 04/17/19
6.05 -10.19%
on 04/01/19
-0.26 (-4.57%)
since 03/25/19
3-Month
4.99 +8.82%
on 04/17/19
14.53 -62.63%
on 01/31/19
-8.40 (-60.74%)
since 01/25/19
52-Week
4.99 +8.82%
on 04/17/19
28.74 -81.11%
on 06/22/18
-16.51 (-75.25%)
since 04/25/18

Most Recent Stories

More News
THURSDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Diplomat Pharmacy, Inc. ("Diplomat" or "the...

DPLO : 5.43 (-1.45%)
Mednax Inc has the Best Relative Performance in the Health Care Services Industry (MD , DPLO , DVA , DGX , PINC )

Below are the top five companies in the Health Care Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

MD : 26.98 (-1.10%)
DVA : 53.68 (-0.65%)
DPLO : 5.43 (-1.45%)
Downtrend Call Working As Diplomat Pharmac Stock Falls 61.8% (DPLO)

SmarTrend identified a Downtrend for Diplomat Pharmac (NYSE:DPLO) on November 7th, 2018 at $14.37. In approximately 6 months, Diplomat Pharmac has returned 61.80% as of today's recent price of $5.49.

DPLO : 5.43 (-1.45%)
DPLO FINAL DEADLINE REMINDER: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important April 25th Deadline in Securities Class Action Filed by the Firm - DPLO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the "Class Period")...

DPLO : 5.43 (-1.45%)
Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

AVEO : 0.89 (-3.26%)
CAG : 31.22 (-0.19%)
DPLO : 5.43 (-1.45%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

BPI : 6.39 (unch)
WTW : 19.07 (-2.41%)
BA : 374.98 (-0.13%)
DPLO : 5.43 (-1.45%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

CTL : 11.47 (-1.04%)
WTW : 19.07 (-2.41%)
BA : 374.98 (-0.13%)
DPLO : 5.43 (-1.45%)
DPLO DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019,...

DPLO : 5.43 (-1.45%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

CVS : 52.91 (-0.04%)
BPI : 6.39 (unch)
BA : 374.98 (-0.13%)
DPLO : 5.43 (-1.45%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline - DPLO

Pomerantz LLP announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) and certain of its officers and directors. The class action,...

DPLO : 5.43 (-1.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade DPLO with:

Business Summary

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including...

See More

Key Turning Points

2nd Resistance Point 5.64
1st Resistance Point 5.58
Last Price 5.43
1st Support Level 5.42
2nd Support Level 5.33

See More

52-Week High 28.74
Fibonacci 61.8% 19.67
Fibonacci 50% 16.86
Fibonacci 38.2% 14.06
Last Price 5.43
52-Week Low 4.99

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar